CpG motif in ATCGAT hexamer improves DNA-vaccine efficiency against lethal Pseudorabies virus infection in pigs (Q45457519)

14 December 2017

title

CpG motif in ATCGAT hexamer improves DNA-vaccine efficiency against lethal Pseudorabies virus infection in pigs (English)

1 reference

14 December 2017

Daniel Dory

1

1 reference

14 December 2017

Véronique Béven

2

1 reference

14 December 2017

Anne-Marie Torché

3

1 reference

14 December 2017

Stéphanie Bougeard

4

1 reference

14 December 2017

Roland Cariolet

5

1 reference

14 December 2017

André Jestin

6

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 August 2005

1 reference

14 December 2017

1 reference

14 December 2017

volume

23

1 reference

14 December 2017

issue

36

1 reference

14 December 2017

page(s)

4532-4540

1 reference

Aujeszky's disease (pseudorabies) virus: the virus and molecular pathogenesis--state of the art, June 1999.

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

Use of a Sindbis virus DNA-based expression vector for induction of protective immunity against pseudorabies virus in pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

DNA vaccination of neonate piglets in the face of maternal immunity induces humoral memory and protection against a virulent pseudorabies virus challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

Quantitative analysis of the antigen-specific IFNgamma T cell-mediated immune response in conventional outbred pigs: kinetics and duration of the DNA-induced IFNgamma CD8 T cell response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

Protection induced by intramuscular immunization with DNA vaccines of pseudorabies in mice, rabbits and piglets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

Induction of porcine cytokine mRNA expression after DNA immunization and pseudorabies virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

Effect of vaccination route and composition of DNA vaccine on the induction of protective immunity against pseudorabies infection in pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

Glycoprotein B of Aujeszky's disease virus: topographical epitope mapping and epitope-specific antibody response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

Distribution of B-cell epitopes on the pseudorabies virus glycoprotein B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

The porcine humoral immune response against pseudorabies virus specifically targets attachment sites on glycoprotein gC.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

A DNA vaccine coding for glycoprotein B of pseudorabies virus induces cell-mediated immunity in pigs and reduces virus excretion early after infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

The potential of oligodeoxynucleotides as mucosal and parenteral adjuvants.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

Oligonucleotide containing CpG motifs enhances immune response to mucosally or systemically administered tetanus toxoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

T helper 2 immunity to hepatitis B surface antigen primed by gene-gun-mediated DNA vaccination can be shifted towards T helper 1 immunity by codelivery of CpG motif-containing oligodeoxynucleotides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

CpG DNA induces stronger immune responses with less toxicity than other adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

CpG motifs in bacterial DNA trigger direct B-cell activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

Antitumor applications of stimulating toll-like receptor 9 with CpG oligodeoxynucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

Adjuvant effect of multi-CpG motifs on an HIV-1 DNA vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

CpG DNA: a potent signal for growth, activation, and maturation of human dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

CpG oligodeoxynucleotide and Montanide ISA 51 adjuvant combination enhanced the protective efficacy of a subunit malaria vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

Augmentation of cellular immune responses to bovine herpesvirus-1 glycoprotein D by vaccination with CpG-enhanced plasmid vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

Response of porcine peripheral blood mononuclear cells to CpG-containing oligodeoxynucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

Type-A CpG oligonucleotides activate exclusively porcine natural interferon-producing cells to secrete interferon-alpha, tumour necrosis factor-alpha and interleukin-12.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

Effective protection of pigs against lethal Pseudorabies virus infection after a single injection of low-dose Sindbis-derived plasmids encoding PrV gB, gC and gD glycoproteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

The potency testing of pseudorabies vaccines in pigs. A proposal for a quantitative criterion and a minimum requirement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

Level of virulent virus excreted by infected pigs previously vaccinated with different glycoprotein deleted Aujeszky's disease vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

Protective antiviral immune responses to pseudorabies virus induced by DNA vaccination using dimethyldioctadecylammonium bromide as an adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

CpG-oligodinucleotides as an effective adjuvant in pigs for intramuscular immunizations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

Induction of protective immunity in pigs after immunisation with CpG oligodeoxynucleotides formulated in a lipid-based delivery system (Biphasix?)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

Immunology. A Toll for DNA vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

Swine Toll-like receptor 9(1) recognizes CpG motifs of human cell stimulant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

Stimulatory effect of CpG sequences on humoral response in chickens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VACCINE.2005.03.046

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2005.03.046

1 reference

14 December 2017

1 reference